Novan, Inc. (NOVN) Stock Price, Financial Report, & Fundamental Analysis

NASDAQ:NOVN

Novan, Inc., a medical dermatology company, focuses on researching, developing, and commercializing therapeutic products for skin diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases.

-1.15%
1D
46.02%
1M
-70.86%
YTD
-68.11%
1Y
-97.04%
5Y
-99.29%
10Y
Add Watchlist Portfolio Analyzer
Stock Price (USD)
1
PER
-0.7x
PBV
4.6x
Market Cap. (USD)
31.15 million
ROA
-43.86%
ROE
-338.08%